CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1051 - 1060 of 1135
Study Number Lead Group Study Title CIRB Study Status
AAML0631 COG Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox IND# 103, 331) during Consolidation: A Phase III Study Limited to COG institutions in the United States & Canada Pediatric CIRB Completed
CALGB-90401 CALGB A Randomized Double-Blinded Placebo Controlled Phase III Trial Comparing Docetaxel and Prednisone with and without Bevacizumab (IND #7921; NSC #704865) in Men with Hormone Refractory Prostate Cancer Adult CIRB - Late Phase Emphasis Completed
GOG-0204 GOG A Randomized Phase III Trial of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Versus Topotecan Plus Cisplatin in Stage IVB; Recurrent; or Persistent Carcinoma of the Cervix Adult CIRB - Late Phase Emphasis Completed
RTOG-0412-SWOG-S0332 RTOG Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients With Stage IIIA (N2) Non-Small Cell Lung Cancer Adult CIRB - Late Phase Emphasis Completed
S0307 SWOG Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer Adult CIRB - Late Phase Emphasis Completed
E1A05 ECOG Randomized Phase III Trial of Consolidation Therapy with Bortezomib (Velcade) - Lenalidomide (Revlimid) - Dexamethasone (VRD) versus Bortezomib (Velcade) - Dexamethasone (VD) for Patients with Multiple Myeloma Who Have Completed a Dexamethasone Based Induction Regimen Adult CIRB - Late Phase Emphasis Completed
ACNS0621 COG Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma: A Groupwide Phase II Study Pediatric CIRB Completed
AHOD0521 COG A Phase II Study of Bortezomib (Velcade; PS-341; IND # 58443) in Combination with Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults with Refractory/Recurrent Hodgkin Disease: A Groupwide Phase II Study Pediatric CIRB Completed
10317 ETCTN A Pilot Study of Nivolumab in Combination with Decitabine and Venetoclax in TP53-mutated Acute Myeloid Leukemia Adult CIRB - Early Phase Emphasis Completed
NRG-GY001 NRG A Phase II Trial of Cabozantinib (XL-184) (NSC #761968) in Women with Recurrent; Clear Cell Carcinoma of the Ovary; Fallopian Tube; or Peritoneum Adult CIRB - Late Phase Emphasis Completed
Displaying 1051 - 1060 of 1135